A drug meant to treat cholesterol was found to reduce coronavirus infection by 70% in lab studies, with researchers calling for additional clinical trials among hospitalized COVID-19 patients.A team of researchers from the U.K. and Italy published findings in the Frontiers in Pharmacology journal Friday, finding that fenofibrate andfenofibric acid resulted in a significant reduction in coronavirus infection in human cells when the drug was used in safe and approved concentrations, according to a news release posted Friday.
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
A cookie is a text file being stored in your device: Computer, Smartphone, etc.
Be aware if you decline to store cookies you will neither be able to Register or Login!
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
A cookie is a text file being stored in your device: Computer, Smartphone, etc.
Be aware if you decline to store cookies you will neither be able to Register or Login!